Compare ARK Genomic Revolution ETF (ARKG) vs Li Auto Inc (LI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Li Auto Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Li Auto Inc trades at $12.02 (market cap $11.97B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Li Auto Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | LI | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $31.80 |
52-Week Low | $23.09 | $11.74 |
Market Cap | — | $11.97B |
Enterprise Value | — | $888.72M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Li Auto (LI) trades at $12.10, down 1.6% with a bearish technical signal. Recent earnings show volatility with Q1 2026 missing estimates, while cash flow turned negative in 2025. The company faces intense competition and margin pressure, though analyst consensus remains cautiously optimistic with a $14.80 price target. Vehicle deliveries reached 30,895 in June 2026, indicating steady demand despite market headwinds.
Outlook hinges on execution of L series models and recovery from 2025-2026 trough years. Risks include aggressive discounting, regulatory challenges, and macroeconomic pressures in China's EV market. The stock presents a speculative opportunity if operational improvements materialize, but near-term volatility is expected.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Li Auto Inc
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →
